Back
Plus Therapeutics Vs. Builders FirstSource Industry Stock Comparison
Buy
52
PSTV
Plus Therapeutics
Last Price:
2.19
Seasonality Move:
95.29%
Sell
49
BLDR
Builders FirstSource
Last Price:
167.00
Seasonality Move:
6.7%
Buy
52
Plus Therapeutics (PSTV)
is a Buy
Is Plus Therapeutics a Buy, Sell or Hold?
- The current Plus Therapeutics [PSTV] share price is $2.24. The Score for PSTV is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- PSTV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Builders FirstSource (BLDR)
is a Sell
Is Builders FirstSource a Buy, Sell or Hold?
- The current Builders FirstSource [BLDR] share price is $167.05. The Score for BLDR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- BLDR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PSTV Stock Price Chart
What is Plus Therapeutics's stock price today?
-
The Plus Therapeutics share price today is $2.24
The current trend is moderately bullish and PSTV is experiencing slight buying pressure.
BLDR Stock Price Chart
What is Builders FirstSource's stock price today?
-
The Builders FirstSource share price today is $167.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLDR is experiencing slight selling pressure.
PSTV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 65.93 | Buy |
| Chaikin Money Flow: | 8080 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.65 - 2.15) | Buy |
| Bollinger Bands (100): | (1.74 - 2.08) | Buy |
BLDR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.4 | Sell |
| Relative Strength Index (14 RSI): | 39.78 | Sell |
| Chaikin Money Flow: | -337678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (168.74 - 189.2) | Sell |
| Bollinger Bands (100): | (169.66 - 198.36) | Sell |
PSTV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.23 | Buy |
| 20-day SMA: | 1.95 | Buy |
| 50-day SMA: | 1.86 | Buy |
| 200-day SMA: | 1.85 | Buy |
| 8-day EMA: | 2.19 | Buy |
| 20-day EMA: | 2.04 | Buy |
| 50-day EMA: | 1.93 | Buy |
| 200-day EMA: | 2.31 | Sell |
BLDR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 167.64 | Sell |
| 20-day SMA: | 178.45 | Sell |
| 50-day SMA: | 189.88 | Sell |
| 200-day SMA: | 158.52 | Buy |
| 8-day EMA: | 170.04 | Sell |
| 20-day EMA: | 176.53 | Sell |
| 50-day EMA: | 182.8 | Sell |
| 200-day EMA: | 161.7 | Buy |
Plus Therapeutics Earnings Growth & PSTV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.76 per share, a decrease next quarter of $0.30 per share, an increase this year of $2.68 per share, and a decrease next year of $0.54 per share.
Builders FirstSource Earnings Growth & BLDR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.49 per share, a decrease this year of $0.87 per share, and an increase next year of $1.33 per share.
Plus Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Builders FirstSource Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||